LBA13 Enozertinib (ORIC-114), a highly selective, brain penetrant EGFR and HER2 inhibitor, in EGFR Exon 20 mutant NSCLC: Randomized dose optimization and CNS activity

T John, N Mohindra, MH Hong, KH Lee, NB Leighl, J Rotow, L Alder, R Dziadziuszko, MG Krebs, J Sabari, A Spira, C Kim, ML Cheng, A Weber, K Velastegui, A Daemen, J Wang, E Chow Maneval, PS Multani, M-J Ahn